Literature DB >> 12714452

Managing Barrett's oesophagus.

Stuart Jon Spechler.   

Abstract

Mesh：

Year:  2003        PMID： 12714452      PMCID： PMC1125811          DOI： 10.1136/bmj.326.7395.892

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

1.  Risk charts: putting cancer in context.

Authors:  Steven Woloshin; Lisa M Schwartz; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2002-06-05       Impact factor: 13.506

Review 2.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

Authors:  N J Shaheen; M A Crosby; E M Bozymski; R S Sandler
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

3.  Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.

Authors:  Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

4.  Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation.

Authors:  V F Eckardt; G Kanzler; G Bernhard
Journal:  Am J Med       Date:  2001-07       Impact factor: 4.965

Review 5.  Short segment Barrett's esophagus--the need for standardization of the definition and of endoscopic criteria.

Authors:  P Sharma; T G Morales; R E Sampliner
Journal:  Am J Gastroenterol       Date:  1998-07       Impact factor: 10.864

6.  p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium.

Authors:  D J Wong; T G Paulson; L J Prevo; P C Galipeau; G Longton; P L Blount; B J Reid
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

7.  Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.

Authors:  D Provenzale; C Schmitt; J B Wong
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

Review 8.  Barrett's-related esophageal adenocarcinoma: is chemoprevention a potential option?

Authors:  M B Fennerty; G Triadafilopoulos
Journal:  Am J Gastroenterol       Date:  2001-08       Impact factor: 10.864

9.  Surveillance and survival in Barrett's adenocarcinomas: a population-based study.

Authors:  Douglas A Corley; Theodore R Levin; Laurel A Habel; Noel S Weiss; Patricia A Buffler
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

10.  Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.

Authors:  John M Inadomi; Richard Sampliner; Jesper Lagergren; David Lieberman; A Mark Fendrick; Nimish Vakil
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391
View more
  7 in total

Review 1.  Barrett's esophagus with high-grade dysplasia: focus on current treatment options.

Authors:  Leonidas Lekakos; Nikolaos P Karidis; Dimitrios Dimitroulis; Christos Tsigris; Gregory Kouraklis; Nikolaos Nikiteas
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

Review 2.  Gastro-oesophageal reflux disease.

Authors:  Mark Fox; Ian Forgacs
Journal:  BMJ       Date:  2006-01-14

3.  The homeodomain protein CDX2 is an early marker of Barrett's oesophagus.

Authors:  L M G Moons; D A Bax; E J Kuipers; H Van Dekken; J Haringsma; A H M Van Vliet; P D Siersema; J G Kusters
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

Review 4.  Photodynamic therapy in gastroenterology.

Authors:  N Shishkova; O Kuznetsova; T Berezov
Journal:  J Gastrointest Cancer       Date:  2013-09

5.  Patient-centered, comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy.

Authors:  Jennifer R Kramer; Jennifer Arney; John Chen; Peter Richardson; Zhigang Duan; Richard L Street; Marilyn Hinojosa-Lindsey; Aanand D Naik; Hashem B El-Serag
Journal:  BMC Health Serv Res       Date:  2012-08-28       Impact factor: 2.655

6.  A labelled discrete choice experiment adds realism to the choices presented: preferences for surveillance tests for Barrett esophagus.

Authors:  Michelle E Kruijshaar; Marie-Louise Essink-Bot; Bas Donkers; Caspar W N Looman; Peter D Siersema; Ewout W Steyerberg
Journal:  BMC Med Res Methodol       Date:  2009-05-19       Impact factor: 4.615

7.  Different perceptions of the burden of upper GI endoscopy: an empirical study in three patient groups.

Authors:  Marie-Louise Essink-Bot; Michelle E Kruijshaar; Dirk J Bac; Pieter J Wismans; Frank ter Borg; Ewout W Steyerberg; Peter D Siersema
Journal:  Qual Life Res       Date:  2007-07-17       Impact factor: 4.147
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.